Use: Labeled indications
- Hypertension
- Coronary Artery Disease
Full indications and usage US FDA label
1 INDICATIONS AND USAGE NORVASC is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:
- Hypertension (1.1) o NORVASC is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
- Coronary Artery Disease (1.2) o Chronic Stable Angina o Vasospastic Angina (Prinzmetal’s or Variant Angina) o Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40% 1.1 Hypertension NORVASC ® is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including NORVASC. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. NORVASC may be used alone or in combination with other antihypertensive agents. 1.2 Coronary Artery Disease (CAD) Chronic Stable Angina NORVASC is indicated for the symptomatic treatment of chronic stable angina. NORVASC may be used alone or in combination with other antianginal agents. Vasospastic Angina (Prinzmetal’s or Variant Angina) NORVASC is indicated for the treatment of confirmed or suspected vasospastic angina. NORVASC may be used as monotherapy or in combination with other antianginal agents. Angiographically Documented CAD In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, NORVASC is indicated to reduce the risk of hospitalization for angina and to reduce the risk of a coronary revascularization procedure.
Contraindications
- Known sensitivity to amlodipine
Contraindications (US label) US FDA label
4 CONTRAINDICATIONS NORVASC is contraindicated in patients with known sensitivity to amlodipine. • Known sensitivity to amlodipine (4)
Dosing: Adult
- Hypertension: 5 mg once daily; maximum 10 mg once daily (2.5 mg start if small, frail, elderly or hepatic insufficiency)
- Chronic stable or vasospastic angina; coronary artery disease: 5 to 10 mg once daily
- • Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. (2.1)
- o Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. (2.1)
- • Pediatric starting dose: 2.5 mg to 5 mg once daily. (2.2)
- Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. (2.2)
2.1 Adults
2.1 Adults The usual initial antihypertensive oral dose of NORVASC is 5 mg once daily, and the maximum dose is 10 mg once daily. Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding NORVASC to other antihypertensive therapy.
Adjust dosage according to blood pressure goals. In general, wait 7 to 14 days between titration steps. Titrate more rapidly, however, if clinically warranted, provided the patient is assessed frequently. Angina: The recommended dose for chronic stable or vasospastic angina is 5–10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency.
Most patients will require 10 mg for adequate effect. Coronary artery disease: The recommended dose range for patients with coronary artery disease is 5–10 mg once daily. In clinical studies, the majority of patients required 10 mg [see Clinical Studies (14.4)].
2.2 Children
2.2 Children The effective antihypertensive oral dose in pediatric patients ages 6–17 years is 2.5 mg to 5 mg once daily. Doses in excess of 5 mg daily have not been studied in pediatric patients [see Clinical Pharmacology (12.4), Clinical Studies (14.1)].
Dosing: Altered kidney function
Amlodipine pharmacokinetics are not significantly affected by kidney impairment, so patients with kidney failure may receive the usual starting dose (US label). It is highly protein bound and not removed by hemodialysis.
Kidney function measure: Label makes no band distinction.
Show full dosing details
- eGFR ≥60
- Usual dosing: 5 mg once daily, maximum 10 mg (label).
- eGFR 30–59
- No adjustment (label).
- eGFR 15–29
- No adjustment (label).
- eGFR <15 (not on dialysis)
- Usual initial dose (label: patients with renal failure).
- Hemodialysis (intermittent)
- No adjustment; hemodialysis is unlikely to remove amlodipine (label, Overdosage).
- Peritoneal dialysis
- No label adjustment; no PD data (amlodipine is hepatically cleared and not dialyzed).
- CRRT
- No data in label.
- Dialyzable? No: highly protein bound; hemodialysis not likely to help (label).
- Monitoring Blood pressure, edema. Lower starting dose (2.5 mg) in older adults and hepatic impairment (label).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- No pediatric kidney data; adult label needs no kidney adjustment.
- eGFR 30–59
- No pediatric kidney data; adult label needs no kidney adjustment.
- eGFR 15–29
- No pediatric kidney data; adult label needs no kidney adjustment.
- eGFR <15 (not on dialysis)
- No pediatric kidney data; adult label needs no kidney adjustment.
- Hemodialysis (intermittent)
- No pediatric data; not dialyzable.
- Peritoneal dialysis
- No pediatric data.
- CRRT
- No pediatric data.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
Dosing: Pediatric
- Approved ages
- Hypertension, 6 to 17 years; effect under 6 years unknown (label).
- Usual dose
- 2.5 to 5 mg once daily (label gives fixed doses, not mg/kg).
- Maximum dose
- 5 mg daily; higher doses not studied in children (label).
- Neonates
- Neonates: not established (under 6 years).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
8.4 Pediatric Use NORVASC (2.5 to 5 mg daily) is effective in lowering blood pressure in patients 6 to 17 years [see Clinical Studies (14.1)]. Effect of NORVASC on blood pressure in patients less than 6 years of age is not known.
Dosing: Older adult
Geriatric use (US label) US FDA label
8.5 Geriatric Use Clinical studies of NORVASC did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Elderly patients have decreased clearance of amlodipine with a resulting increase of AUC of approximately 40–60%, and a lower initial dose may be required [see Dosage and Administration (2.1)].
Dosage forms
Philippines
- Tablet: 2.5 mg, 5 mg, 10 mg, 20 mg
- Film-coated tablet: 5 mg, 10 mg, 10 mg/320 mg/25 mg
Registered products in the Philippines
383 products registered with the Food and Drug Administration (FDA) Philippines list Amlodipine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products383
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
4CHBAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raaphael Archangel Pharmaceutical Product Distribution | DRP-5800-09 | Nov 14, 2029 | |
4CHBAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION | DRP-5806-08 | Nov 14, 2029 | |
AcarvaAmlodipine (as besilate) | 10mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Novagen Healthcare Private LimitedIndia | Novocore Pharma Inc.Importer: I.E. Medica, Inc. | DRP-16060-01 | Oct 29, 2029 | |
AcarvaAmlodipine (as besilate) | 5mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Novagen Healthcare Private LimitedIndia | Novocare Pharma Inc.Importer: I.E. Medica, Inc. | DRP-16058-01 | Oct 29, 2029 | |
AforbesAmlodipine (as besilate) | 10 mg TabletAluminum Foil Strip x 10's (Box of 100's) | RxVAT-exempt | PT. Merck TbkIndonesia | Merck, Inc. | DR-XY38183 | Jul 6, 2031 | |
AforbesAmlodipine (as besilate) | 5 mg TabletAluminum Foil Strip x 10's (Box of 100's) | RxVAT-exempt | PT. Merck Tbk.Indonesia | Importer: Merck, Inc. | DR-XY34226 | Feb 6, 2028 | |
AlodineAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | XL Laboratories Pvt. Ltd.India | Starpharm, Inc.Importer: Ambica International Corporation | DRP-2250-01 | Nov 18, 2029 | |
Alodine-10Amlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Starpharm, Inc. | DRP-5800-19 | Nov 14, 2029 | |
Alodine-5Amlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Starpharm, Inc. | DRP-5806-17 | Nov 14, 2029 | |
AmadayAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Chempro Pharma Pvt. Ltd.India | Virrod Inc.Importer: Ambica International Corporation | DRP-5763-03 | Apr 28, 2027 | |
AmadayAmlodipine (as besilate) | 5 mg TabletAlu/ PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Chempro Pharma Pvt. Ltd.India | Virrod Inc.Importer: Ambica International Corporation | DRP-5739-03 | Apr 28, 2027 | |
AmairAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | East African (India) OverseasIndia | Airlife International Trading Corporation | DRP-15434 | Jul 9, 2029 | |
AmalvexAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Hiral Labs LimitedIndia | Mc Graw Pharma Inc.Importer: Aglobal Care, Inc. | DRP-7376-01 | Feb 7, 2032 | |
AmalvexAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Mc Graw Pharma Inc.Importer: Aglobal Care, Inc. | DRP-7563-01 | Feb 7, 2032 | |
AmbesylAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic. A.S.Turkey | Importer: Sandoz Philippines Corporation | DRP-1629 | Apr 23, 2030 | |
AmbesylAmlodipine (As Besilate) | 5 mg TabletPVC/PVDC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic A.S.Turkey | Sandoz Philippines Corporation | DRP-1276 | Apr 23, 2030 | |
AmblosylAmlodipine (as besilate) | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | CSPC Ouyi Pharmaceutical Co. Ltd.China | AMB HK Enterprises Inc. | DRP-3553 | May 27, 2029 | |
AmblosylAmlodipine (as besilate) | 5 mg TabletPVC/Alu Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-3554 | May 19, 2027 | |
AmclorAmlodipine (as Besilate) | 10 mg TabletLDPE Laminated Alu Foil Strip x 10's (Box of 100's) | RxVAT-exempt | Torrent Pharmaceuticals Ltd.India | Torrent Pharma Philippines, Inc. | DRP-2727 | Sep 12, 2029 | |
AmdipineAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's - Treatment Pack for DOH) | RxVAT-exempt | Mercury Laboratories Ltd.India | Phil Pharmawealth, Inc. | DR-XY45278 | Apr 18, 2031 | |
AmdipineAmlodipine (as besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's - Treatment Pack for DOH) | RxVAT-exempt | Mercury Laboratories Ltd.India | Phil Pharmawealth, Inc. | DR-XY45272 | Apr 18, 2031 | |
AmexiAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-08 | Nov 14, 2029 | |
Amlion-10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-4458 | Jun 6, 2028 | |
Amlion-5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-4778 | Oct 8, 2028 | |
AmlixAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Flamingo Pharmaceuticals Ltd.India | Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals | DRP-1147-02 | Nov 16, 2027 | |
Amlo Med-10Amlodipine (as besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Interhealthcare Pharmaceuticals, Inc. | DRP-4847-03 | Aug 25, 2031 | |
Amlo Med-5Amlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-5319-02 | Aug 6, 2031 | |
AmlocareAmlodipine (as besilate) | 10 mg Film-Coated TabletWhite PVC Blister Pack x 10's Box of 100's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Totalcare Pharma Inc. | DR-XY36723 | Sep 29, 2029 | |
AmlocareAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Totalcare Pharma Inc. | DR-XY36722 | Sep 29, 2029 | |
AmlocaredAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Jaac Healthline Marketing | DRP-5800-17 | Nov 14, 2029 | |
AmlocaredAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Jaac Healthline Marketing | DRP-5806-14 | Nov 14, 2029 | |
AmlocorAmlodipine (As Besilate) | 5 mg TabletAlu-Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | TORRENT PHARMACEUTICALS LTD.India | Torrent Pharma Philippines, Inc. | DRP-2726 | Jul 21, 2028 | |
AmlodacAmlodipine (as Besilate) | 10 mg Film-Coated TabletPVC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Zydus Lifesciences LimitedIndia | Zydus Healthcare Philippines, Inc. | DRP-1201 | Dec 3, 2032 | |
AmlodacAmlodipine (as besilate) | 5 mg Film Coated TabletPVC/Alu Blister Pack x 10's (Box of 100's); PVC/Alu Blister Pack x 10's (Box of 10's as Physician's Sample) | RxVAT-exempt | Zydus Lifesciences LimitedIndia | Zydus Healthcare Philippines Inc., | DRP-1288 | Aug 19, 2028 | |
Amlodac 10Amlodipine (as besilate) | 10 mg TabletAlu/PVDC blister pack x 10's [Box of 10's (for physician's sample) and 100's] | RxVAT-exempt | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines Inc | DRP-16375 | Feb 24, 2030 | |
Amlodac 5Amlodipine (as besilate) | 5 mg TabletAlu/PVDC blister pack x 10's [Box of 10's (for physician's sample) and 100's] | RxVAT-exempt | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines Inc. | DRP-16374 | Feb 24, 2030 | |
AmlodiblocAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 7's (Box of 14's); Alu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Jiangsu Pengyao Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY43278 | Mar 7, 2029 | |
AmlodiblocAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 7's (Box of 14's); Alu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's - Treatment Pack for DOH) | RxVAT-exempt | Jiangsu Pengyao Pharmaceutical Co., Ltd.China | Global Pharmatrade | DR-XY43279 | Mar 7, 2029 | |
AmlodineAmlodipine (as besilate) | 10 mg TabletWhite PVC/Alu Blister Pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-6314 | Jul 2, 2027 | |
AmlodineAmlodipine (as besilate) | 5 mg TabletBlister Pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-6313 | Sep 12, 2027 | |
AmlodipexAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Zeutica, Inc. | DRP-4373-09 | Mar 28, 2031 | |
AmlodisanAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Hiral Labs LimitedIndia | Sannovex Pharmaceutical DistributorImporter: Aglobal Care, Inc. | DRP-7376-10 | Feb 7, 2032 | |
AmlodisanAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Hiral Labs LimitedIndia | Sannovex Pharmaceutical DistributorImporter: Aglobal Care, Inc. | DRP-7563-07 | Feb 12, 2032 | |
AmlodnAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-07 | Nov 14, 2029 | |
AmlodnAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 100's; Alu/Clear PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5806-07 | Nov 14, 2029 | |
AmlofarAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Healer's Lab. (Unit II)India | Pharmakon Biotec Inc. | DRP-5164 | Feb 21, 2029 | |
AmlofirstAmlodipine (as Besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Metro Manila | Firstmed Theraconcept, Inc. | DRP-3495-02 | Aug 26, 2031 | |
AmlofirstAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories, Inc.Metro Manila | Firstmed Theraconcept, Inc. | DRP-3536-05 | Apr 11, 2031 | |
AmlogAmlodipine (as Besilate) | 10mg TabletAmber colored PVC/PVDC-aluminium foil blister pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises Inc. | DRP-13068 | Nov 24, 2027 | |
AmlogAmlodipine (as Besilate) | 5mg TabletAmber colored PVC/PVDC-aluminium foil blister pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises Inc. | DRP-13067 | Nov 24, 2027 | |
Amlogold-10Amlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-5800-26 | Nov 14, 2029 | |
Amlogold-5Amlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-5806-24 | Nov 14, 2029 | |
AmlohartAmlodipine (as besilate) | 10 mg TabletAlu Clear PVDC Blister Pack x 10's (Box of 30's & Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DR-XY40060 | Sep 16, 2031 | |
AmlohartAmlodipine (as besilate) | 5 mg TabletClear PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DR-XY40063 | Sep 16, 2031 | |
Amlokard (Reformulated)Amlodipine (as besilate) | 10 mg TabletAluminum Strip Foil x 10's (Box of 30's & 100's) | RxVAT-exempt | Interphil Laboratories,IncPhilippines | — | DRP-4727 | Sep 23, 2028 | |
Amlokard (Reformulated)Amlodipine (as besilate) | 5 mg TabletAlu/PET Foil Strip x 10's Box of 30's; Alu/PET Foil Strip x 10's Box of 100's; Alu/PET Foil Strip x 10's Box of 10's as Physician's Sample; Alu/PET Foil Strip x 2's Box of 2's as Physician's Sample | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | — | DRP-1338 | Jul 12, 2028 | |
Amlomed-5Amlodipine (as besilate) | 5 mg TabletAlu/ Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Medchem International Ltd.India | Pharma-Surrey International, Inc. | DRP-964 | Feb 19, 2028 | |
AmlomelAmlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Amiel Trading Inc. | DRP-5800-22 | Nov 14, 2029 | |
AmlomelAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Amiel Trading Inc. | DRP-5806-20 | Nov 14, 2029 | |
AmlonAmlodipine (as besilate) | 10 mg TabletAlu/Clear PVC Blister pack x 10's (Box of 50's) | RxVAT-exempt | Biopharma Laboratories Ltd.Bangladesh | JF Draf Pharmaceuticals Corporation | DRP-2906 | Jan 7, 2031 | |
AmlonAmlodipine (as besilate) | 5 mg TabletPVC/ Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Biopharma Laboratories LimitedBangladesh | JF Draf Pharmaceuticals Corporation | DRP-3485 | Jul 14, 2031 | |
AmlonavAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Healer's Lab (Unit II)India | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-5164-01 | Feb 21, 2029 | |
AmlopigenAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-5800-04 | Nov 14, 2029 | |
AmlopigenAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 60's and 100's | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | EBA GENERISCH TRADING INC. | DRP-5806-04 | Nov 14, 2029 | |
AmlopinAmlodipine (as besilate) | 5 mg TabletAlu Foil Strip x 10’s (Box of 100’s) | RxVAT-exempt | Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)India | Clearvue PharmaceuticalImporter: Ambica International Corporation | DRP-2111-04 | Apr 16, 2027 | |
AmlopinAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | CV Clearvue Pharma, Inc.Importer: Ambica International Corporation | DRP-4778-11 | Oct 8, 2028 | |
Amlopure-10Amlodipine (As Besilate) | 10 mg TabletAlu/Alu Blister Pack X 10’s (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | AGLOBAL CARE,aAglobal Care, Inc. INC.Importer: Aglobal Care, Inc. | DRP-7376 | Feb 26, 2031 | |
Amlopure-5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack X 10’s (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Aglobal Care, Inc. | DRP-7563 | Dec 17, 2030 | |
AmlorexAmlodipine (as besilate) | 10 mg TabletOrange PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | — | DRP-2621 | Apr 28, 2030 | |
AmlorexAmlodipine (as Besilate) | 5 mg TabletAlu-Orange PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | — | DRP-2639 | Jun 1, 2030 | |
AmlorhAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-4778-10 | Oct 8, 2028 | |
Amlosaph-10Amlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's, 60's, 90's and 100's); Alu/PVC Blister Pack x 20's (Box of 100's); Alu/PVC Blister Pack x 25's (Box of 100's) | RxVAT-exempt | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-12747 | Jan 21, 2032 | |
Amlosaph-5Amlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's, 60's, 90's and 100's); Alu/PVC Blister Pack x 20's (Box of 100's); Alu/PVC Blister Pack x 25's (Box of 100's) | RxVAT-exempt | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-12144 | Jan 21, 2032 | |
AMLOSave 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack X 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc. | DRP-11636-06 | Apr 4, 2027 | |
Amlosave 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack X 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc. | DRP-11635-06 | Apr 4, 2027 | |
AmlosilAmlodipine (as Besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Metro Manila | Westfield Pharmaceuticals, Inc. | DRP-3495-03 | Aug 26, 2031 | |
AmlosilAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-3536-02 | Feb 7, 2032 | |
AmloskyAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4458-08 | Jun 6, 2028 | |
AmloskyAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4778-07 | Oct 8, 2028 | |
Amlospeed 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4458-09 | Jun 6, 2028 | |
Amlospeed 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4778-08 | Oct 8, 2028 | |
AmlostanAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | Gold Life Distribution Phils. Inc. | DRP-3536-03 | Dec 13, 2031 | |
AmlosylAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Intas Pharmaceuticals LimitedIndia | Phil Pharmawealth, Inc. | DR-XY37194 | Dec 17, 2029 | |
AmlosylAmlodipine (as Besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's and 30's - Treatment Pack for DOH) | RxVAT-exempt | Intas Pharmaceuticals Ltd.India | Phil Pharmawealth, Inc. | DR-XY37190 | Dec 17, 2029 | |
AmlotecAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack of 30's (Box of 90's & 300's) | RxVAT-exempt | Ravian Life Science Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-4968 | Nov 29, 2028 | |
AmlotechAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-12 | Nov 14, 2029 | |
AmlotechAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 20's Box of 100's; Alu Clear PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5806-10 | Nov 14, 2029 | |
AmlothAmlodipine (as besilate) | 10 mg TabletAlu/Alu Foil Strip x 10's (Box of 100's) | RxVAT-exempt | ZEST PHARMAIndia | SAHAR INTERNATIONAL TRADING INC. | DR-XY41291 | Oct 2, 2027 | |
AmlothinAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-11 | Nov 14, 2029 | |
AmlothinAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION | DRP-5806-09 | Nov 14, 2029 | |
AmlothixAmlodipine (as besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Novagen Healthcare Private Limited.India | I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd | DRP-16059 | Oct 29, 2029 | |
AmlothixAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister pack x 14's Box of 100's and 140's | RxVAT-exempt | Plethico Pharmaceuticals Ltd.India | Medethix, Inc.Importer: I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd. | DRP-993-03 | Jan 30, 2028 | |
AmlothixAmlodipine (as besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Novagen Healthcare Private Limited.India | I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd. | DRP-16057 | Oct 29, 2029 | |
AmlothixAmlodipine ( as besilate) | 5 mg tabletAlu/PVC Blister pack x 14's (Box of 140's); Alu/PVC Blister pack x 10's (Box of 100's) | RxVAT-exempt | Plethico Pharmaceuticals Ltd.India | Medethix, Inc.Importer: I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd. | DRP-994-03 | Jan 30, 2028 | |
AmlotrazAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 30’s and 100’s) | RxVAT-exempt | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-3201 | Apr 1, 2038 | |
AmlotrazAmlodipine (as Besilate) | 5 mg TabletAlu/Alu Blister Pack x 10’s (Box of 10’s and 100’s) | RxVAT-exempt | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-3200 | Apr 1, 2037 | |
AmlovacAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 50's) | RxVAT-exempt | Celogen Generics Private Ltd.India | Endure Medical, Inc. | DR-XY48189 | Mar 26, 2031 | |
Amlovic-10Amlodipine (as besilate) | 10 mg Tablet | RxVAT-exempt | J Duncan Healthcare Pvt. Ltd. | Grovic Pharma Inc. | DRP-7491 | Nov 22, 2026 | |
AmlovinAmlodipine (as Besilate) | 10 mg Film-Coated TabletAlu/PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6760 | Jun 19, 2029 | |
AmlovinAmlodipine (as besilate) | 5 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6759 | Nov 18, 2029 | |
Amlus-10Amlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Hiral Labs LimitedIndia | Bellus Life Solutions, Inc.Importer: Aglobal Care, Inc. | DRP-7376-04 | Feb 26, 2031 | |
Amlus-5Amlodipine (as besilate) | 5mg TabletAlu/Alu Blister Pack X 10’s (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Bellus Life Solutions, Inc.Importer: Aglobal Care, Inc. | DRP-7563-04 | Dec 17, 2030 | |
AmlytrolAmlodipine (as besilate) | 10 mg TabletWhite Opaque PVC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-3108-05 | Jul 8, 2031 | |
AmlytrolAmlodipine (as besilate) | 5 mg TabletWhite Opaque PVC / Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-4373-07 | Sep 22, 2031 | |
Amnique 5Amlodipine (as besilate) | 5 mg TabletAlu Foil Strip x 10's (Box of 30's and 100's) | RxVAT-exempt | Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals Limited)India | JBCPL Philippines Inc. | DRP-2111 | Apr 16, 2027 | |
Amo 10Amlodipine (As Besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Delta Pharma Ltd.Bangladesh | Biomed Pharma Inc. | DR-XY38306 | Jul 28, 2031 | |
Amo 5Amlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Delta Pharma Ltd.Bangladesh | Importer: Biomed Pharma Inc. | DR-XY38440 | Oct 5, 2031 | |
AmpressAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack 3 x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading, Inc. | DRP-13922 | May 24, 2028 | |
AmpressAmlodipine (As Besilate) | 5 mg TabletAlu/Alu Blister Pack of 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc. | DRP-13190 | Dec 16, 2027 | |
AmsiveAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | Medirich Pharma Distribution Corp.A | DRP-3536-01 | Feb 6, 2032 | |
AMVASC BEAmlodipine (as besilate) | 10 mg TabletAluminum Flex Foil x 10s Box of 50's | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DRP-1195 | Oct 9, 2027 | |
Amvasc BEAmlodipine (as Besilate) | 5 mg TabletAluminum Flex Foil x 10's Box of 50's | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DRP-1202 | Jun 20, 2028 | |
AmvicAmlodipine (as besilate) | 10 mg TabletAluminum Foil Amber-colored PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | J. Duncan Healthcare Pvt. Ltd.India | Multigro Healthcare Inc.Importer: Grovic Pharma Inc. | DRP-7491-01 | Nov 22, 2026 | |
AmzurAmlodipine (As Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-13327 | Jan 27, 2028 | |
AmzurAmlodipine (as besylate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-13841 | May 3, 2028 | |
AprenormAmlodipine (as besilate) | 10 mg TabletAlu/PVDC Film-White Blister Pack x 10's Box of 30's, 50's, 100's | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | — | DRP-1334 | Feb 5, 2029 | |
AprenormAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | — | DRP-1357 | Feb 19, 2029 | |
Artivess PlusAmlodipine (as besilate) | 10 mg/ 320mg/ 25mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Healer's Lab Unit IIIndia | Pharmakon Biotec Inc. | DRP-16894 | Aug 11, 2030 | |
AvtorexAmlodipine (As Besilate) | 10mg TabletAlu/Alu blister pack x 10 tablets (box of 30 tablets) | RxVAT-exempt | Replek Farm Ltd.Macedonia | Spey Philippines, Inc.Trader: Spey Medical Ltd. | DRP-11783 | Apr 28, 2027 | |
AvtorexAmlodipine (as besilate) | 5mg TabletAlu/Alu blister pack x 10 tablets (box of 30 tablets) | RxVAT-exempt | Replek Farm Ltd.Macedonia | Spey Philippines, Inc.Trader: Spey Medical Ltd. | DRP-11784 | Apr 28, 2027 | |
BesilopinAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Jjysrinn Trading Inc.Importer: Ambica International Corporation | DRP-4458-06 | Jun 6, 2028 | |
BesilopinAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Jjysrinn Trading Inc.Importer: Ambica International Corporation | DRP-4778-06 | Oct 8, 2028 | |
BesylonAmlodipine (as Besilate) | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY37033 | Nov 20, 2029 | |
BesylonAmlodipine (as Besilate) | 5 mg Film-Coated TabletAlu/White PVC Blister Pack x 10 (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Inc. | DR-XY37204 | Dec 15, 2029 | |
BezamAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Berlin Pharmaceutical Industry Co., Ltd.Thailand | Littman Drug CorporationTrader: Paradigm Pharma (Thailand) Co. | DR-XY44803 | Sep 3, 2030 | |
BezamAmlodipine (as besilate) | 5mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Berlin Pharmaceutical Co., Ltd.Thailand | Littman Drug CorporationTrader: Paradigm Pharma (Thailand) Co. | DR-XY44775 | Sep 3, 2030 | |
BlocapastAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10’s Box of 100’s | RxVAT-exempt | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-774 | Nov 16, 2027 | |
Blocapast ForteAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-1147 | Nov 16, 2027 | |
BPCheck 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | One Technodrug Life Sciences Inc.Importer: Teramedix Pharma Trading Inc. | DRP-13922-01 | May 24, 2028 | |
BPCheck 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | One Technodrug Life Sciences Inc.Importer: Teramedix Pharma Trading Inc. | DRP-13190-02 | Dec 16, 2027 | |
BPCureAmlodipine (as besilate) | 10 mg TabletWhite Opaque PVC /Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Gogenerx Pharma. Inc. | DRP-3108-07 | Jul 8, 2031 | |
BPCureAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Gogenerx Pharma. Inc | DRP-4373-05 | Aug 26, 2031 | |
BptrolAmlodipine (as besilate) | 10 mg TabletWhite Opaque PVC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | — | DRP-3108 | Jul 8, 2031 | |
BptrolAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's); Alu/White Opaque PVC Blister Pack Physician's sample x 1's | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | — | DRP-4373 | Mar 28, 2031 | |
CalblocAmlodipine (as Besilate) | 10 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Medilife Pharma, Inc. | DRP-1439 | May 26, 2029 | |
CALBLOCAmlodipine (as Besilate) | 5 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Medilife Pharma, Inc. | DRP-1440 | May 26, 2029 | |
Calcebis 10Amlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | 228 Pharma TradingImporter: Ambica International Corporation | DRP-4458-04 | Jun 6, 2028 | |
Calcebis 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | 228 Pharma TradingImporter: Ambica International Corporation | DRP-4778-04 | Oct 8, 2028 | |
CalcivasAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Philippines, Inc. | DRP-832 | Nov 29, 2029 | |
CalcivasAmlodipine (as Besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's Box of 50's | RxVAT-exempt | Micro Labs LimitedIndia | Brown & Burk Philippines IncImporter: Brown & Burk Philippines Inc. | DRP-816 | Nov 29, 2029 | |
CalpineAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Suhitas Pharmaceuticals, Inc.Trader: Mac Heal Laboratories Ltd. | DRP-3408 | Dec 1, 2031 | |
CalpineAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-3305 | Oct 11, 2031 | |
Calpress-5Amlodipine (as Besilate) | 5 mg TabletWhite PVDC Blister Pack x 14's (Box of 28's); White PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Ipca Laboratories Ltd.India | Blue Global (FZE) | DRP-3077 | Aug 8, 2031 | |
CardiovascAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic. A.S.Turkey | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-1629-01 | Apr 23, 2030 | |
CardiovascAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic. A.S.Turkey | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-1276-01 | Apr 23, 2030 | |
CardiovitAmlodipine (as besilate) | 5 mg TabletOrange PVC/Alu Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | LifeSquare Laboratories, Inc.Philippines | — | DRP-3858 | Sep 4, 2031 | |
CARDIVASCAmlodipine (as besilate) | 5 mg TabletAluminum Foil Strip x 10's Box of 100's | RxVAT-exempt | EL LABORATORIES, INC.Philippines | Trader: THE CATHAY YSS DISTRIBUTORS CO., INC. | DR-XY36005 | Jun 19, 2029 | |
Carepro GenericsAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.174101 India | Cecile’s PharmacyImporter: Teramedix Pharma Trading Inc. | DRP-13190-03 | Dec 16, 2027 | |
CHBNXTAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-06 | Nov 14, 2029 | |
CHBNXTAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | ST. RAPHAEL ARCHANGEL PHARMACEUTICAL PRODUCT DISTRIBUTION | DRP-5806-06 | Nov 14, 2029 | |
CorpulaxAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Corbridge Group Phil., Inc.Importer: I.E. Medica, Inc. | DRP-6613-02 | Apr 6, 2029 | |
CorpulaxAmlodipine (as besilate) | 20 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Corbridge Group Phil., Inc.Importer: I.E. Medica, Inc. | DRP-6617-02 | Apr 6, 2029 | |
CorpulaxAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Corbridge Group Phils., Inc.Importer: I.E. Medica, Inc. | DRP-6616-02 | Feb 2, 2032 | |
DailypineAmlodipine (as besilate) | 5 mg TabletAmber colored PVC/PVDC-aluminum foil blister pack x 10 (Box of 30’s) | RxVAT-exempt | Globela Pharma Private LimitedIndia | Maraki Pharma Co.Importer: Amb Hk Enterprises Inc. | DRP-13067-01 | Nov 24, 2027 | |
DailyvascAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Micro Labs LimitedIndia | ADP Pharma CorporationImporter: Brown & Burk Phils., Inc. | DRP-832-01 | Nov 29, 2029 | |
DailyvascAmlodipine (as Besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 50's) | RxVAT-exempt | Micro Labs LimitedIndia | ADP Pharma CorporationImporter: Brown and Burk Phils., Inc. | DRP-816-01 | Nov 29, 2029 | |
DanlopinAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | D & G PharmaImporter: Ambica International Corporation | DRP-4458-01 | Jun 6, 2028 | |
DanlopinAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | D & G PharmaImporter: Ambica International Corporation | DRP-4778-01 | Oct 8, 2028 | |
Derox 10Amlodipine (as Besilate) | 10 mg TabletWhite Opaque Alu/PVC Blister Pack x 10 ' s (Box of 30's) | RxVAT-exempt | Hovid BerhadMalaysia | Hovid, Inc. | DR-XY42263 | Jul 23, 2028 | |
DiadipineAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 20's Box of 100's; Alu/PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-6992 | Jul 18, 2027 | |
DiadipineAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister pack x 20's (Box of 100’s); Alu/PVC Blister pack x 10's (Box of 30's) | RxVAT-exempt | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-6994 | Jul 18, 2032 | |
DilavascAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | XL Laboratories Pvt. Ltd.India | Primera Pharma Corp.Importer: Ambica International Corporation | DRP-2250-02 | Nov 18, 2029 | |
DilavascAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | XL Laboratories Pvt. Ltd.India | Primera Pharma Corp.Importer: Ambica International Corporation | DRP-2249-01 | Nov 18, 2029 | |
Dipexine 10Amlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-5800-01 | Nov 14, 2029 | |
Dipexine 5Amlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 60's and 100's | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | 999 SETH PHARMACEUTICAL INC. | DRP-5806-01 | Nov 14, 2029 | |
Dipiglo 10Amlodipine (as Besilate) | 10mg TabletAmber-colored PVC/PVDC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-12901 | Oct 27, 2027 | |
DipinewAmlodipine ( as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-14027 | Jun 6, 2028 | |
DipinewAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-12488 | Aug 19, 2032 | |
DiploAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Theon Pharmaceuticals LimitedIndia | Hexagon Pharmaceuticals | DRP-16730 | Jul 1, 2030 | |
DocvascAmlodipine (as besilate) | 10 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Phil. United Pharma CorporationPhilippines | Trader: Docteur's Choice Corporation | DRP-12132 | Jun 17, 2027 | |
DocvascAmlodipine (as besilate) | 5 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Phil. United Pharma CorporationPhilippines | Trader: Docteur's Choice Corporation | DRP-12133 | Jun 17, 2027 | |
Emlip-10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | XL Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-2250 | Nov 18, 2029 | |
Emlip-5Amlodipine (as Besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | XL Laboratories Pvt. Ltd.India | Phil Asia Pharma Inc.Importer: Ambica International Corporation | DRP-2249 | Nov 18, 2029 | |
Eodipine 10Amlodipine (as besilate) | 10 mg tabletAlu/PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | SAI MIRRA INNOPHARM PVT., LTDIndia | EON PHARMATEK, INC | DR-XY36539 | Aug 19, 2029 | |
Eodipine 10Amlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ciron Drugs & Pharmaceuticals Pvt. LtdIndia | Eon Pharmatek Inc.Trader: Subira Pharmaceutical Pvt. Ltd. | DR-XY48391 | Oct 5, 2032 | |
Eodipine 5Amlodipine (as Besilate) | 5 mg TabletAmber Colored Alu/PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Sai Mirra Innopharm Pvt. Ltd.India | Eon Pharmatek, Inc. | DR-XY47014 | Apr 12, 2031 | |
Eodipine 5Amlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ciron Drugs & Pharmaceuticals Pvt. Ltd.India | Eon Pharmatek Inc.Trader: Subira Pharmaceuticals Pvt. Ltd. | DR-XY48392 | Oct 5, 2027 | |
ErapinAmlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Errapel Pharmed Corp. | DRP-5800-21 | Nov 14, 2029 | |
ErapinAmlodipine (as Besilate) | 5 mg TabletAlu Clear Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Errapel Pharmed Corp. | DRP-5806-19 | Nov 14, 2029 | |
Eurovasc-5Amlodipine (as besilate) | 5 mg TabletAlu Foil Strip x 10’s (Box of 30’s) | RxVAT-exempt | Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)India | Euroasia Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-2111-01 | Apr 16, 2027 | |
Genvasc-10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceutical Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11636-01 | Apr 4, 2027 | |
Genvasc-5Amlodipine (as besilate) | 5mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceutical Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11635-01 | Apr 4, 2027 | |
GolvascAmlodipine (as besilate) | 10 mg TabletAlu/PVC blister pack x 10’s (Box of 100’s) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | Trader: Golden Dale Pharma Corp. | DRP-10850 | Dec 6, 2026 | |
GolvascAmlodipine (as besilate) | 5 mg TabletAlu/PVC blister pack x 10’s (Box of 100’s) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | Trader: Golden Dale Pharma Corp. | DRP-10851 | Dec 6, 2026 | |
Gopres 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceutical Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11636-02 | Apr 4, 2027 | |
Gopres-5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11635-02 | Apr 4, 2027 | |
HartvascAmlodipine (as besilate) | 10 mg TabletAlu/PVDC Film-White Blister Pack x 10's (Box of 50's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Pharma Dynamic, Inc. | DRP-1334-06 | Feb 5, 2029 | |
HemlobAmlodipine (as besilate) | 10 mg TabletAlu/PVC blister pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Hebei Tiancheng Pharmaceutical Co., Ltd.China | Philrx Pharma Inc. | DRP-16302 | Jan 31, 2030 | |
HemlobAmlodipine (as besilate) | 5 mg TabletAlu/PVC blister pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Hebei Tiancheng Pharmaceutical Co., Ltd.China | Philrx Pharma Inc. | DRP-16301 | Jan 31, 2030 | |
Hylodine HBAmlodipine (as Besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Generics Pharmacal Phils., Inc. | DRP-4373-10 | Mar 28, 2031 | |
IvatrolAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Jickstar Pharma Inc. | DRP-4373-08 | Aug 28, 2031 | |
JohnvascAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 20’s (Box of 100’s) | RxVAT-exempt | SAN MARINO LABORATORIES CORPORATIONPhilippines | Trader: JOHNTANN INTERNATIONALE PHARMACEUTICAL CORP. | DRP-8096 | Jun 15, 2027 | |
Juliadipine 10Amlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's & 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Botika ni-Julia | DRP-5800-23 | Nov 14, 2029 | |
Juliadipine 5Amlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's & 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Botika ni-Julia | DRP-5806-21 | Nov 14, 2029 | |
Khrizdipine 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 10's) | RxVAT-exempt | Celogen Generics Private Ltd.India | Khriz Pharma Trading Inc. | DR-XY48956 | Dec 22, 2028 | |
KodapineAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Kodapharm Med Corp. | DRP-5800-16 | Nov 14, 2029 | |
KodapineAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Kodapharm Med Corp. | DRP-5806-15 | Nov 14, 2029 | |
KodipinAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30's); Alu/Clear PVC Blister Pack x 20’s (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience And Drug Store Corp. | DRP-5806-13 | Nov 14, 2029 | |
KodipineAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Kodi Biosciences Inc.Importer: AGlobal Care, Inc. | DRP-7376-08 | Feb 26, 2031 | |
Kodipine 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Kodi Biosciences IncImporter: Pharmakon Biotec Inc. | DRP-13841-02 | May 3, 2028 | |
Lewidipine (Reformulated)Amlodipine (as besilate) | 10 mg TabletAluminum Strip Foil x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Lewison Pharmaceutical Corporation | DRP-4727-02 | Sep 23, 2028 | |
LodiAmlodipine (as besilate) | 10 mg TabletAlu/PVDC Film-White Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | GX International, Inc. | DRP-1334-07 | Feb 5, 2029 | |
LodiAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | GX INTERNATIONAL, INC. | DRP-1357-06 | Feb 19, 2029 | |
LodibesAmlodipine (as besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | TGP Pharma Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-4847 | Mar 11, 2031 | |
LodibesAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | TGP Pharma IncTrader: Interhealthcare Pharmaceuticals Inc. | DRP-5319 | Mar 11, 2030 | |
LodibizAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Pharmabiz Solutions, Inc. | DRP-2425 | Mar 12, 2031 | |
LodibizAmlodipine (as besilate) | 5 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Pharmabiz Solutions, Inc. | DRP-2794 | Mar 12, 2031 | |
LodicorAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories, Inc.Philippines | HEI Gruppo Pharmaceutica, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-5319-01 | Aug 17, 2031 | |
LodifiveAmlodipine (as besilate) | 5 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | Neo Care Philippines, Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11635-07 | Apr 4, 2027 | |
LodipAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Bulaca | One Health Marketing Inc. | DRP-5806-25 | Nov 14, 2029 | |
LodipenAmlodipine (as Besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Centurion Laboratories Pvt. Ltd.India | Philgen Pharmaceuticals Inc. | DRP-1890 | May 13, 2027 | |
LodipenAmlodipine (as besilate) | 5 mg TabletAlu/Amber PVC Blister Pack x 10's (Box of 100's and 30's) | RxVAT-exempt | Centurion Laboratories Pvt. Ltd.India | Philgen Pharmaceuticals Inc. | DRP-1887 | May 16, 2027 | |
LodipexAmlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-5800 | Nov 14, 2029 | |
LodipexAmlodipine (As Besilate) | 5 mg TabletAlu/Clear Pvc Blister Pack X 40'S / (Box Of 120'S And 200'S) Alu/Clear Pvc Blister Pack X 20'S / (Box Of 60'S And 100'S) Alu/Clear Pvc Blister Pack X 10'S / (Box Of 30'S) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Source Inc. | — | DRP-5806 | Nov 14, 2029 | |
LoditenAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Neo Care Philippines, Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11636-07 | Apr 4, 2027 | |
LopicardAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | RxVAT-exempt | Getz Pharma Pvt. Ltd.Pakistan | Getz Pharma (Phils.), Inc. | DR-XY41856 | Sep 2, 2030 | |
LopicardAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) Alu/Alu Blister Pack x 1's Box of 1's - Physician Sample | RxVAT-exempt | Getz Pharma Pvt. Ltd.Pakistan | Getz Pharma (Phils.), Inc. | DR-XY33802 | Sep 2, 2030 | |
LopidenAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5800-10 | Nov 14, 2029 | |
LopidenAmlodipine (as Besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5806-05 | Nov 14, 2029 | |
LopivascAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite PVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY39423 | May 18, 2031 | |
LorvascAmlodipine Besilate | 10 mg TabletALUMINUM FOIL / PVC BLISTER PACK X 10'S (BOX OF 100'S) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | N/ATrader: ATC Healthcare International Corp. | DRP-10848 | Dec 6, 2026 | |
LorvascAmlodipine Besilate | 5 mg TabletALUMINUM FOIL / PVC BLISTER PACK X 10'S (BOX OF 100'S) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | N/ATrader: ATC Healthcare International Corp. | DRP-10849 | Dec 6, 2026 | |
Mablodipine-10Amlodipine (As Besilate) | 10 mg TabletAlu/Alu Blister Pack X 10’s (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Medconcern Drugs and General Merchandise Inc.Importer: AGlobal Care, Inc. | DRP-7376-12 | Feb 26, 2031 | |
Mablodipine-5Amlodipine (as besilate) | 5 mg TabletAlu/ Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Medconcern Drugs and General Merchandise Inc.Importer: Aglobal Care, Inc. | DRP-7563-09 | Dec 17, 2030 | |
MadovinAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | The Madras PharmaceuticalsIndia | Aglobal Care, Inc. | DRP-14601 | Oct 26, 2028 | |
Malapine-10Amlodipine (As Besilate) | 10 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Malyka International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-6149-01 | Mar 25, 2031 | |
Malapine-5Amlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Malyka International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-6148-01 | Apr 1, 2031 | |
Medpin-10Amlodipine (As Besilate) | 10 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnamani Healthcare Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-11636 | Apr 4, 2027 | |
Medpin-5Amlodipine (As Besilate) | 5 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnamani Healthcare Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-11635 | Apr 4, 2027 | |
Miosil-10Amlodipine (as besilate) | 10 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-6149 | Mar 15, 2031 | |
Miosil-5Amlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Medisure Laboratories Pakistan (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-6148 | Mar 16, 2031 | |
Mybloc-5Amlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 30's (Box of 90's and 300's) | RxVAT-exempt | Ravian Life Science Pvt. Ltd.India | Teramedix Pharma Trading IncImporter: Pharmakon Biotec Inc. | DRP-4968-01 | Nov 29, 2028 | |
NavlodineAmlodipine (as besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/ Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Metro Manila | JN Carlo Pharmaceuticals Distributor | DRP-3495-06 | Aug 26, 2031 | |
NavlodineAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/ Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. TOLMANN LABORATORIES INC.Philippines | JN Carlo Pharmaceuticals Distributor | DRP-3536-07 | Apr 11, 2031 | |
NeldipinAmlodipine (As Besilate) | 10mg TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-12315 | Jul 13, 2027 | |
NeldipinAmlodipine (as besilate) | 5mg TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-12321 | Jul 13, 2027 | |
NeocardAmlodipine (as besilate) | 10 mg TabletWhite Opaque PVC / Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Metro Manila | Pro Medica Inc. | DRP-3108-04 | Jul 8, 2036 | |
NepidolAmlodipine (as besilate) | 10 mg TabletOrange PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-2621-02 | Feb 25, 2031 | |
NepidolAmlodipine (as Besilate) | 5 mg TabletAlu-Orange PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-2639-02 | Apr 1, 2031 | |
NervatrolAmlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-5800-25 | Nov 14, 2029 | |
NervatrolAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-5806-23 | Nov 14, 2029 | |
NoneAmlodipine (as Besilate) | 10 mg Film- Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-3495 | Aug 26, 2031 | |
NoneAmlodipine (as besilate) | 10 mg Film-Coated TabletWhite PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Dyna Drug Corporation | DR-XY36714 | Sep 29, 2029 | |
NoneAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | — | DR-XY42490 | Sep 2, 2028 | |
NoneAmlodipine (as Besilate) | 10 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DR-XY44432 | Apr 15, 2030 | |
NoneAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu / White PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DRP-17347 | Apr 15, 2030 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | — | DRP-10852 | Dec 6, 2026 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Flamingo Pharmaceuticals Ltd.India | Qualifirst Health Inc.Importer: Hexagon Pharmaceuticals | DRP-1147-04 | Nov 16, 2027 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | MED4UImporter: Medinova Pharmaceutical Inc. | DRP-11636-08 | Apr 4, 2027 | |
NoneAmlodipine (as besilate) | 10 mg TabletAluminum Flex Foil x 10s Box of 50s | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | RITEMED PHILS., INC.Trader: UNILAB, INC. | DRP-1195-03 | Oct 9, 2027 | |
NoneAmlodipine (as besilate ) | 10 mg TabletAmber -colored PVC/PVDC/Alu Blister Pack x 10's (Box of 30's and Box of 100's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | Dyna Drug CorporationImporter: AMB HK Enterprises, Inc. | DRP-12901-03 | Oct 27, 2027 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc. | DRP-13327-01 | Jan 27, 2028 | |
NoneAmlodipine (as Besilate) | 10 mg TabletAlu/PVDC Film-White Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Actimed, Inc. | DRP-1334-10 | Feb 5, 2029 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 30’s) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Cyden Medicale Trading Inc.Importer: Teramedix Pharma Trading Inc. | DRP-13922-02 | May 24, 2028 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-14027-01 | Jun 6, 2028 | |
NoneAmlodipine (as Besilate) | 10 mg TabletRed Blister Pack x 10's (Box of 100's); Red Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Drugmaker's Laboratories, Inc.Philippines | — | DRP-1615 | Jan 30, 2031 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu-PVC Blister Pack x 14's (Box of 28's) | RxVAT-exempt | Ind-Swift LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-2220-02 | Oct 14, 2031 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/White Opaque PVC/PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Viatris Pharmaceuticals LLCUSA | Philusa CorporationImporter: Viatris, Inc. | DRP-3429-01 | Mar 7, 2031 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu / White Opaque PVC/PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Viatris LLCUSA | Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc. | DRP-3429-02 | Feb 7, 2030 | |
NoneAmlodipine (as Besilate) | 10 mg TabletPVC/Alu Blister Pack x 10's Box of 30's and 100's | RxVAT-exempt | CSPC OUYI PHARMACEUTICALS CO. LTD.China | FARMACIA NI DOK, INC.Importer: AMB HK ENTERPRISES INC. | DRP-3553-02 | May 27, 2029 | |
NoneAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | ATC Healthcare International CorporationImporter: Ambica International Corporation | DRP-4458-05 | Jun 6, 2028 | |
NoneAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | South Star DrugImporter: Ambica International Corporation | DRP-4458-07 | Jun 6, 2028 | |
NoneAmlodipine (as besilate) | 10 mg TabletAluminum Strip Foil x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Neodrug Inc. | DRP-4727-03 | Sep 23, 2028 | |
NoneAmlodipine (as besilate) | 10 mg TabletAluminum Strip Foil x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Rose Pharmacy, Incorporated | DRP-4727-05 | Sep 23, 2028 | |
NoneAmlodipine (as besilate) | 10 mg TabletAluminum Strip Foil x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | St. Joseph Drugstore | DRP-4727-06 | Sep 23, 2028 | |
NoneAmlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | BEWISE TRADING CORP. Doing business under the name & style of PHARMAPLUS GENERIC & BRANDED DRUG DISTRIBUTOR & MEDICAL SUPPLIES | DRP-5800-18 | Nov 14, 2029 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's); Alu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Actimed, Inc.Importer: I.E. Medica, Inc. | DRP-6613 | Apr 6, 2029 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Patriot Pharmaceuticals CorporationImporter: I.E. Medica, Inc. | DRP-6613-03 | Apr 6, 2029 | |
NoneAmlodipine (As Besilate) | 10 mg TabletAlu / Alu Blister Pack X 10’s (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | SwissPharmatech Co.Importer: Aglobal Care, Inc. | DRP-7376-11 | Feb 26, 2031 | |
NoneAmlodipine (as besilate) | 10 mg tabletAlu/PVC Blister pack x 10's (Box of 100's); Alu/PVC Blister pack x 14's (Box of 140's); Alu/PVC Blister pack x 10's (Box 30's DOH use only) | RxVAT-exempt | Plethico Pharmaceuticals Ltd.India | I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd. | DRP-993 | Jan 30, 2028 | |
NoneAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Plethico Pharmaceuticals Ltd.India | Vivilon Pharmaceuticals Inc.Importer: I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd. | DRP-993-04 | Jan 30, 2028 | |
NoneAmlodipine (as besilate) | 20 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private LimitedIndia | Actimed, Inc.Importer: I.E. Medica, Inc, | DRP-6617 | Apr 6, 2029 | |
NoneAmlodipine (as besilate) | 5 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | — | DR-XY42465 | Aug 29, 2028 | |
NoneAmlodipine (as Besilate) | 5 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DR-XY44589 | May 25, 2030 | |
NoneAmlodipine (as Besilate) | 5 mg Film-Coated TabletAlu/ White PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DRP-17346 | May 25, 2030 | |
NoneAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories, Inc.Philippines | Gamot Philippines, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-5319-03 | Sep 11, 2031 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Phil. United Pharma Corp.Philippines | — | DRP-10853 | Dec 6, 2026 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Private LimitedIndia | MED4UImporter: Medinova Pharmaceutical Inc. | DRP-11635-08 | Apr 4, 2027 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sydenham Laboratories, Inc.Philippines | Actimed, Inc. | DRP-1185-01 | Nov 7, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAluminum Flex Foil by 10's (Box of 50's) | RxVAT-exempt | Amherst Laboratories, Inc.Philippines | RiteMed Phils, Inc.Trader: UNILAB, INC. | DRP-1202-03 | Jun 20, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sapphire Lifesciences Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Nelpa Lifesciences, Inc. | DRP-12144-02 | Jun 22, 2027 | |
NoneAmlodipine (as besilate) | 5 mg TabletPVC/PVDC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic A.S.Turkey | Ritemed Philippines, Inc.Importer: Sandoz Philippines Corporation | DRP-1276-03 | Aug 8, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/PET Foil Strip x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | St. Joseph Drugstore | DRP-1338-06 | Jul 12, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVDC blister pack x 10's (Box of 100's) | RxVAT-exempt | Hizon LaboratoriesPhilippines | BOIE INCORPORATED | DRP-1357-05 | Feb 19, 2029 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVDC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Actimed, Inc. | DRP-1357-11 | Feb 19, 2029 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu-PVC Blister Pack x 14's (Box of 28's) | RxVAT-exempt | Ind-Swift LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-2219-02 | Nov 19, 2031 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC/PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Viatris Pharmaceuticals LLCUSA | Philusa CorporationImporter: Viatris, Inc. | DRP-3419-01 | Feb 24, 2031 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVC/PVDC Blister pack x 10's (Box of 100's); Alu/White Opaque PVC/PVDC Blister Pack x 1's (Box of 1's) | RxVAT-exempt | Viatris Pharmaceuticals LLCUSA | Viatris Pharmaceuticals, Inc.Importer: Viatris, Inc. | DRP-3419-02 | Feb 7, 2030 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-4778-05 | Oct 8, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4778-09 | Oct 8, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-4778-12 | Oct 8, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 30's (Box of 90's) | RxVAT-exempt | Ravian Life Science Pvt. Ltd.India | Zydus Healthcare Philippines IncImporter: Pharmakon Biotec Inc. | DRP-4968-02 | Nov 29, 2028 | |
NoneAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | BEWISE TRADING CORP. Doing business under the name & style of Pharmaplus Generic & Branded Drug Distributor & Medical Supplies | DRP-5806-16 | Nov 14, 2029 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Mars Therapeutics Private Ltd.India | Patriot Pharmaceuticals CorporationImporter: I.E. Medica, Inc. | DRP-6616-03 | Apr 6, 2030 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu / Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | SwissPharmatech Co.Importer: Aglobal Care, Inc. | DRP-7563-08 | Dec 17, 2030 | |
NoneAmlodipine (as Besilate) | 5 mg TabletAlu/Red PVC Blister Pack x 25's (Box of 100's) | RxVAT-exempt | Vonwelt Inc.Philippines | — | DRP-7671 | Apr 21, 2028 | |
NoneAmlodipine (as besilate) | 5 mg TabletAlu / Alu Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Flamingo Pharmaceuticals Ltd.India | Qualifirst Health Inc.Importer: Hexagon Pharmaceuticals | DRP-774-05 | Nov 16, 2027 | |
NoneAmlodipine (as Besilate) | 5 mg TabletAlu/PVC Blister x 10's Box of 100's; Alu/PVC Blister x 14's Box of 140's | RxVAT-exempt | Plethico Pharmaceuticals Ltd.India | I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd. | DRP-994 | Jan 30, 2028 | |
NoneAmlodipine (as besilate) | 5 mg Tablet (Reformulated)Alu/PET Foil Strip x 10's (Box of 10's and 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Rose Pharmacy, Incorporated | DRP-1338-04 | Jul 21, 2028 | |
NoneAmlodipine (as besilate) | 5mg TabletRed PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Drugmaker's Laboratories, Inc.Philippines | — | DRP-1255 | Sep 3, 2030 | |
None (Reformulated)Amlodipine (as besilate) | 5 mg TabletAlu/PET Foil Strip x 10's (Box of 100's) | RxVAT-exempt | Interphil Laboratories, Inc.Philippines | Neodrug Inc. | DRP-1338-02 | Jul 12, 2028 | |
NorcareAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | EURO-CARE PRODUCTS PHILIPPINES | DRP-5800-05 | Nov 14, 2029 | |
NorvacAmlodipine (as besilate) | 10 mg TabletOrange PVC/ Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-2621-03 | Apr 5, 2031 | |
NorvacAmlodipine (as Besilate) | 5 mg TabletAlu-Orange PVC Blister Pack x 20's (Box of 100's) | RxVAT-exempt | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-2639-01 | Apr 5, 2031 | |
NorvascAmlodipine (as besilate) | 10 mg TabletAlu/White Opaque PVC/PVDC Blister Pack x 10's Box of 100's | RxVAT-exempt | Viatris Pharmaceuticals LLCUSA | Importer: Viatris, Inc. | DRP-3429 | Feb 7, 2030 | |
NorvascAmlodipine (as besilate) | 2.5 mg TabletPVC/PVDC Blister Pack with aluminum backing x 10's (Box of 100's); PVC/PVDC Blister Pack with aluminum backing x 1's (Box of 2's) as Physician's Sample | RxVAT-exempt | Pfizer Global Supply Japan Inc. (Nagoya Plant)Japan | Importer: PF OFG Philippines Inc. | DR-XY45953 | Jul 17, 2027 | |
NorvascAmlodipine (as besilate) | 2.5 mg TabletPVC/PVDC Blister Pack with aluminum backing x 10's (Box of 100's); PVC/PVDC Blister Pack with aluminum backing x 1's (Box of 2's) as Physician's Sample | RxVAT-exempt | Pfizer Global Supply Japan Inc. (Nagoya Plant)Japan | Importer: Viatris, Inc. | DRP-15693 | Jul 17, 2027 | |
NorvascAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC/PVDC Blister Pack x 10's (Box of 100's); Alu/White Opaque PVC/PVDC Blister Pack x 1's (Box of 1's) | RxVAT-exempt | Viatris Pharmaceuticals LLCUSA | Importer: Viatris, Inc. | DRP-3419 | Feb 7, 2030 | |
NorvatrolAmlodipine (as besilate) | 10 mg TabletWhite Opaque PVC/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Metro Manila | Meedpharma Medical Supplies & Equipment Distributor | DRP-3108-03 | Jul 8, 2031 | |
NorvatrolAmlodipine (as besilate) | 5 mg TabletAlu / White Opaque PVC Blister Pack x 10's (Box of 100') | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Meedpharma Medical Supplies & Equipment Distributor | DRP-4373-04 | Sep 22, 2031 | |
NorzanAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical and Pharma Inc. | DRP-5806-22 | Nov 14, 2029 | |
Norzan-10Amlodipine (as Besilate) | 10 mg TabletAlu Clear PVC Blister Pack x 40's (Box of 120's and 200's); Alu Clear PVC Blister Pack x 20's (Box of 60's and 100's); Alu Clear PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical And Pharma Inc. | DRP-5800-24 | Nov 14, 2029 | |
Novalife 10Amlodipine (as besilate) | 10 mg TabletAmber-colored PVC/PVDC/Alu Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc. | DRP-12901-02 | Oct 27, 2027 | |
Novalife 5Amlodipine (as besilate) | 5 mg TabletAlu/Amber Colored PVC-PVDC Blister Pack x 10's (Box of 10's, 30's and 100's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc. | DRP-11390-02 | Mar 8, 2027 | |
OdasylAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Chempro Pharma Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-5763-01 | Apr 28, 2027 | |
OdasylAmlodipine (as Besilate) | 10mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sapphire Lifesciences Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Aaron Healthcare and Export Pvt. Ltd. | DRP-12747-01 | Sep 30, 2027 | |
OdasylAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Chempro Pharma Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-5739-01 | Apr 28, 2027 | |
OdasylAmlodipine (as besilate) | 5mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sapphire Lifesciences Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences, Inc. | DRP-12144-01 | Dec 3, 2026 | |
Odipine 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Strip Foil x 10's Box of 30's | RxVAT-exempt | Oman Pharmaceutical Products Co., L.L.C.Oman | Atlantic Pharmaceuticals, Inc. | DR-XY44254 | Mar 11, 2030 | |
PamlodipineAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | C & S Medical Solutions Inc.Importer: Aglobal Care, Inc. | DRP-7376-09 | Feb 26, 2031 | |
Pamlodipine 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | C & S Medical Solutions Inc.Importer: Pharmakon Biotec Inc. | DRP-13841-01 | May 3, 2028 | |
PhilvascAmlodipine (as besilate) | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | CSPC Ouyi Pharmaceutical Co. Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-3553-01 | May 27, 2029 | |
PhilvascAmlodipine (as besilate) | 10mg TabletAmber-colored PVC/PVDC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12901-01 | Oct 27, 2027 | |
PhilvascAmlodipine (as besilate) | 5 mg TabletAlu/Amber Colored PVC-PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-11390-01 | Mar 8, 2027 | |
Primodil 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Medley Pharmaceuticals LimitedIndia | Healol Pharma Corporation | DR-XY37770 | Apr 12, 2027 | |
Proamlo 10Amlodipine (as besilate) | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Emil Pharmaceutical Industries Private LimitedIndia | Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd. | DRP-5763 | Apr 28, 2032 | |
Proamlo 5Amlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | RxVAT-exempt | Chempro Pharma Pvt. Ltd.India | Ambica International Corporation | DRP-5739 | Apr 28, 2027 | |
PRODIPINEAMLODIPINE (AS BESILATE) | 5 MG FILM-COATED TABLETWHITE OPAQUE PVC/ALU BLISTER PACK X 20'S BOX OF 100'S | RxVAT-exempt | J.M. TOLMANN LABORATORIES INC.Philippines | — | DRP-3536 | Apr 11, 2031 | |
ProvascAmlodipine (as besilate) | 10 mg TabletAlu / PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories Ltd.Bangladesh | Bell-Kenz Pharma, Inc.Importer: Euro Generics International Phils., Inc. | DRP-2206 | Sep 17, 2027 | |
ProvascAmlodipine (as besilate) | 5 mg TabletAlu / PVC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | The ACME Laboratories Ltd.Bangladesh | Bell-Kenz Pharma, Inc.Importer: Euro Generics International Phil., Inc. | DRP-2214 | Sep 17, 2027 | |
Pulsalife 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu blister pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-11636-05 | Apr 4, 2027 | |
Pulsalife 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack X 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-11635-05 | Apr 4, 2027 | |
RedipineAmlodipine (as besilate) | 10 mg TabletAlu/PVC Blister pack x 10's (box of 30's, 60's, 90's and 100's) | RxVAT-exempt | Innovative HealthcareIndia | Biophil Medical Equipment and Supplies Trading | DRP-18866 | Sep 16, 2031 | |
RedipineAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister pack of 10's (Box of 30's, 60's, 90's and 100's) | RxVAT-exempt | Innovative HealthcareIndia | Biophil Medical Equipment and Supplies Trading | DRP-18867 | Sep 16, 2031 | |
RegivascAmlodipine (as Besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-5800-13 | Nov 14, 2029 | |
RegivascAmlodipine (as Besilate) | 5 mg TabletAlu Clear PVC Blister Pack x 20's (Box of 60's and 100's) | RxVAT-exempt | Azarias Pharmaceutical Laboratories Inc.Philippines | REGIMED PHARMACEUTICAL DISTRIBUTOR | DRP-5806-11 | Nov 14, 2029 | |
RETAVASC-10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Reta DrugImporter: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-3408-01 | Dec 1, 2026 | |
Retavasc-5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hiral Labs LimitedIndia | Reta DrugImporter: Aglobal Care, Inc. | DRP-7563-05 | Dec 17, 2030 | |
Retavasc-AAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Reta DrugImporter: Ambica International Corporation | DRP-4778-13 | Oct 8, 2028 | |
SainyoAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's Box of 100's | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Diafarm, Inc.Importer: Ambica International Corporation | DRP-4458-02 | Jun 6, 2028 | |
SainyoAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-4778-02 | Oct 8, 2028 | |
Shelodine-10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Kain's Trading Corp.Importer: Pharmakon Biotec Inc. | DRP-13327-02 | Jan 27, 2028 | |
Shelodine-5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Kain's Trading Corp.Importer: Pharmakon Biotec Inc. | DRP-13841-03 | May 3, 2028 | |
SolvascAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY35525 | Mar 3, 2029 | |
SolvascAmlodipine (as besilate) | 10 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-14981 | Mar 3, 2029 | |
SolvascAmlodipine (as besilate) | 5 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-12877 | Mar 3, 2029 | |
StadovasAmlodipine (as besilate) | 5mg TabletPVC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Stellapharm J.V. Co., Ltd. - Branch 1Vietnam | STADA Philippines Inc | DR-XY40698 | Jun 25, 2027 | |
Swamlo 10Amlodipine (as besilate) | 10 mg TabletAlu-PVC Blister Pack x 14's (Box of 28's and Box of 98's); Alu-PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ind-Swift LimitedIndia | Ambica International Corporation | DRP-2220 | Oct 7, 2031 | |
Swamlo 5Amlodipine (as besilate) | 5 mg TabletAlu-PVC Blister Pack x 14's (Box of 28's and Box of 98's); Alu-PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ind-Swift LimitedIndia | Ambica International Corporation | DRP-2219 | Oct 7, 2031 | |
SylodipineAmlodipine (as besilate) | 10 mg TabletAlu-PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sydenham Laboratories, Inc.Cavite | — | DRP-1676 | Jul 13, 2031 | |
SylodipineAmlodipine (as besilate) | 5 mg TabletAlu/PVC Blister Pack x 10's Box of 100's | RxVAT-exempt | Sydenham Laboratories, Inc.Philippines | Isopharma Inc. | DRP-1185 | Nov 7, 2028 | |
TG AmlomaxAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite Opaque PVC / Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories Inc.Philippines | Tgif Pharmaceutical Trading Inc. | DRP-3536-06 | Jan 22, 2032 | |
UnbrandedAmlodipine (as besilate) | 10 mg Film-Coated TabletWhite Opaque PVC/Alu Blister Pack x 20's (Box of 100's) | RxVAT-exempt | J.M. Tolmann Laboratories, Inc.Philippines | Gamot Philippines, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-4847-02 | Aug 17, 2031 | |
UnbrandedAmlodipine (as besilate) | 10 mg TabletAlu-PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sydenham Laboratories, Inc.Cavite | Actimed, Inc. | DRP-1676-02 | Jul 13, 2031 | |
UnbrandedAmlodipine (as besilate) | 5 mg Film-Coated TabletWhite PVC Blister Pack x 10's Box of 30's | RxVAT-exempt | Lloyd Laboratories, Inc.Philippines | Trader: Dyna Drug Corporation | DR-XY36713 | Sep 28, 2029 | |
UnbrandedAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-12489 | Aug 19, 2032 | |
UnbrandedAmlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC Blister Pack x 10's Alu/White Opaque PVC Blister Pack x 10's (Box of 100's); Alu/White Opaque PVC Blister Pack X l's (Physician's Sample) | RxVAT-exempt | Scheele Laboratories Phils., Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc.Importer: RiteMED Phils., Inc. | DRP-4373-02 | Mar 28, 2031 | |
UnbrandedAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's and 30's) | RxVAT-exempt | Mars Therapeutics Private Ltd.India | Actimed, Inc.Importer: I.E. Medica, Inc. | DRP-6616 | Apr 6, 2030 | |
UnbrandedAmlodipine (as besilate) | 5mg TabletRed PVC blister pack x 10's (Box of 100's) | RxVAT-exempt | Drugmaker's Laboratories IncPhilippines | TGP Pharma Inc. | DRP-1255-03 | Sep 22, 2031 | |
VarodipineAmlodipine(as Besilate) | 5 mg TabletWhite Opaque PVC/Alu Blister Pack x 10’s (Box of 30’s) | RxVAT-exempt | Shin Poong Pharmaceutical Co., Ltd.Korea | Phil. Shinpoong Pharma Inc. | DRP-3660 | Aug 26, 2031 | |
VasalatAmlodipine (as besilate) | 10mg TabletBlister Pack x 10's (Box of 30's and 100's); Blister Pack x 5's (Box of 15's) | RxVAT-exempt | Apotex, Inc.Canada | Patriot Pharmaceuticals Corporation | DR-XY33805 | Sep 13, 2032 | |
VasalatAmlodipine ( as besilate) | 5 mg TabletBlister Pack x 10's (Box of 30's and 100's); Blister Pack x 5's (Box of 15's) | RxVAT-exempt | Apotex, Inc.Canada | Patriot Pharmaceuticals Corporation | DR-XY33804 | Sep 13, 2032 | |
Vasconov 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack X 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-11636-03 | Apr 4, 2027 | |
Vasconov 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack X 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-11635-04 | Apr 4, 2027 | |
VaselonAmlodipine (as besilate) | 10 mg TabletAlu/PVDC Film-White Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Sigma Medical Solution Trading Co., Inc. | DRP-1334-03 | Feb 5, 2029 | |
VaselonAmlodipine (as besilate) | 5 mg TabletAlu/White opaque PVDC Blister Pack x 10's Box of 100's | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Sigma Medical Solution Trading Co., Inc. | DRP-1357-02 | Feb 19, 2029 | |
VasinorAmlodipine (as Besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Synmedic LaboratoriesIndia | Vispomed EnterprisesImporter: Ambica International Corporation | DRP-5065 | Jun 15, 2028 | |
Vesselax 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Magbro Healthcare Pvt. Ltd.India | Alpha Farmaceutico Corp.Importer: Teramedix Pharma Trading Inc. | DRP-13190-01 | Dec 16, 2027 | |
VesselcureAmlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-4458-03 | Jun 6, 2028 | |
VesselcureAmlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Stallion Laboratories Pvt. Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-4778-03 | Oct 8, 2029 | |
WilomaxAmlodipine (as besilate) | 10 mg TabletAlu/PVDC Film-white Blister Pack x 10’s (Box of 100’s) | RxVAT-exempt | Hizon Laboratories, Inc.Philippines | Willore Pharma Corporation | DRP-1334-02 | Feb 5, 2029 | |
Xentravasc 10Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Xentra Medica Cebu Corp.Importer: Medinova Pharmaceutical Inc. | DRP-11636-04 | Apr 4, 2027 | |
Xentravasc 5Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Ratnatris Pharmaceuticals Pvt. Ltd.India | Xentra Medica Cebu Corp.Importer: Medinova Pharmaceutical Inc. | DRP-11635-03 | Apr 4, 2027 | |
(no brand name)Amlodipine (as besilate) | 10 mg TabletAlu/White Opaque PVC-PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | The Government Pharmaceutical Organization (Production Plant I-GPO Thanyaburi)Thailand | Importer: AAA Pharma, Inc. | DR-XY48086 | Jun 3, 2027 | |
(no brand name)Amlodipine (as besilate) | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Novagen Healthcare Private LimitedIndia | I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd | DRP-16060 | Oct 29, 2029 | |
(no brand name)Amlodipine (as besilate) | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. ve Tic. A.S.Turkey | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-1629-03 | Apr 23, 2030 | |
(no brand name)Amlodipine (as besilate) | 10mg TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Cadila Pharmaceuticals LimitedIndia | OneSource Pharma Solutions, Inc. | DRP-10905 | Dec 15, 2026 | |
(no brand name)Amlodipine (as besilate) | 10mg TabletAmber-colored PVC/PVDC/Alu Blister Pack x 10's (Box of 30's) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-12902 | Oct 27, 2027 | |
(no brand name)Amlodipine (As Besilate) | 10mg TabletAmber colored PVC/PVDC-aluminium foil blister pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises Inc. | DRP-13162 | Dec 14, 2027 | |
(no brand name)Amlodipine (as besilate) | 5 mg TabletAlu/White Opaque PVC-PVDC Blister Pack x 10's (Box of 30's) | RxVAT-exempt | The Government Pharmaceutical Organization (Production Plant I-GPO Thanyaburi)Thailand | Importer: AAA Pharma, Inc. | DR-XY48109 | Jun 17, 2027 | |
(no brand name)Amlodipine (as besilate) | 5 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Sandoz Grup Saglik Urunleri Ilaclari San. Ve Tic A.S.Turkey | Ritemed Philippines, Inc.Importer: Sandoz Philippines Corporation | DRP- 1276-03 | Apr 23, 2030 | |
(no brand name)Amlodipine (as besilate) | 5 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | RxVAT-exempt | Novagen Healthcare Private Limited.India | I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd. | DRP-16058 | Oct 29, 2029 | |
(no brand name)Amlodipine (As Besilate) | 5mg TabletAmber colored PVC/PVDC-aluminium foil blister pack x 10's (Box of 3 blister packs x 10 tablets) | RxVAT-exempt | Globela Pharma Private LimitedIndia | AMB HK Enterprises Inc. | DRP-13163 | Dec 14, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS Tablets: 2.5 mg white, diamond, flat-faced, beveled edged, with “NORVASC” on one side and “2.5” on the other Tablets: 5 mg white, elongated octagon, flat-faced, beveled edged, engraved with both “NORVASC” and “5” on one side and plain on the other Tablets: 10 mg white, round, flat-faced, beveled edged, engraved with both “NORVASC” and “10” on one side and plain on the other • Tablets: 2.5 mg, 5 mg, and 10 mg (3)
Warnings/Precautions
- • Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely. (5.1)
- • Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORVASC, particularly in patients with severe obstructive coronary artery disease. (5.2)
- • Titrate slowly in patients with severe hepatic impairment. (5.3)
5.1 Hypotension
5.1 Hypotension Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. Because of the gradual onset of action, acute hypotension is unlikely.
5.2 Increased Angina or Myocardial Infarction
5.2 Increased Angina or Myocardial Infarction Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORVASC, particularly in patients with severe obstructive coronary artery disease.
5.3 Patients with Hepatic Failure Because
5.3 Patients with Hepatic Failure Because NORVASC is extensively metabolized by the liver and the plasma elimination half‑life (t 1/2) is 56 hours in patients with impaired hepatic function, titrate slowly when administering NORVASC to patients with severe hepatic impairment.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Simvastatin | Adjust or monitor | Amlodipine 10 mg raised simvastatin exposure by 77%. | Do not exceed simvastatin 20 mg daily. |
| Moderate and strong CYP3A inhibitors (e.g., diltiazem, itraconazole, clarithromycin) | Adjust or monitor | Higher amlodipine exposure (diltiazem: +60%). | Watch for hypotension and edema; reduce the dose if needed. |
| Cyclosporine, tacrolimus | Adjust or monitor | Higher immunosuppressant levels (cyclosporine trough about +40% in kidney transplant patients; tacrolimus up to 2.5- to 4-fold). | Monitor trough levels often and adjust the dose. |
| CYP3A inducers | Adjust or monitor | Effect on amlodipine not quantified. | Monitor blood pressure closely. |
| Sildenafil | Minor | Additive blood pressure lowering. | Monitor for hypotension. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewed- Do not exceed doses greater than 20 mg daily of simvastatin. (7.2)
7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration
7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)].
CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers. Sildenafil Monitor for hypotension when sildenafil is co-administered with amlodipine [see Clinical Pharmacology (12.2)].
7.2 Impact of Amlodipine on Other Drugs Simvastatin
7.2 Impact of Amlodipine on Other Drugs Simvastatin Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily [see Clinical Pharmacology (12.3)]. Immunosuppressants Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.
Frequent monitoring of trough blood levels of cyclosporine and tacrolimus is recommended and adjust the dose when appropriate [see Clinical Pharmacology (12.3)]. Drug interactions Sildenafil When amlodipine and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect [see Drug Interactions (7.1)].
Drug interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Impact of other drugs on amlodipine Co-administered cimetidine, magnesium-and aluminum hydroxide antacids, sildenafil, and grapefruit juice have no impact on the exposure to amlodipine.
CYP3A inhibitors: Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure. Erythromycin co-administration in healthy volunteers did not significantly change amlodipine systemic exposure. However, strong inhibitors of CYP3A (e.g., itraconazole, clarithromycin) may increase the plasma concentrations of amlodipine to a greater extent [see Drug Interactions (7.1)].
Impact of amlodipine on other drugs Amlodipine is a weak inhibitor of CYP3A and may increase exposure to CYP3A substrates. Co-administered amlodipine does not affect the exposure to atorvastatin, digoxin, ethanol and the warfarin prothrombin response time. Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone [see Drug Interactions (7.2)].
Cyclosporine: A prospective study in renal transplant patients (N=11) showed on an average of 40% increase in trough cyclosporine levels when concomitantly treated with amlodipine [see Drug Interactions (7.2)]. Tacrolimus: A prospective study in healthy Chinese volunteers (N=9) with CYP3A5 expressers showed a 2.5- to 4-fold increase in tacrolimus exposure when concomitantly administered with amlodipine compared to tacrolimus alone.
This finding was not observed in CYP3A5 non-expressers (N= 6). However, a 3-fold increase in plasma exposure to tacrolimus in a renal transplant patient (CYP3A5 non-expresser) upon initiation of amlodipine for the treatment of post-transplant hypertension resulting in reduction of tacrolimus dose has been reported. Irrespective of the CYP3A5 genotype status, the possibility of an interaction cannot be excluded with these drugs [see Drug Interactions (7.2)].
Metabolism and transporters (CYP, P-gp, OATP; US label) US FDA label
CYP3A inhibitors : Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure.
However, strong inhibitors of CYP3A (e.g., itraconazole, clarithromycin) may increase the plasma concentrations of amlodipine to a greater extent [see Drug Interactions (7.1) ] .
Impact of amlodipine on other drugs Amlodipine is a weak inhibitor of CYP3A and may increase exposure to CYP3A substrates.
Tacrolimus : A prospective study in healthy Chinese volunteers (N=9) with CYP3A5 expressers showed a 2.5- to 4-fold increase in tacrolimus exposure when concomitantly administered with amlodipine compared to tacrolimus alone.
This finding was not observed in CYP3A5 non-expressers (N= 6).
However, a 3-fold increase in plasma exposure to tacrolimus in a renal transplant patient (CYP3A5 non-expresser) upon initiation of amlodipine for the treatment of post-transplant hypertension resulting in reduction of tacrolimus dose has been reported.
Irrespective of the CYP3A5 genotype status, the possibility of an interaction cannot be excluded with these drugs [see Drug Interactions (7.2) ] .
( 7.2 ) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.
Adverse reactions
Common
- Edema (dose related: 1.8% at 2.5 mg, 3.0% at 5 mg, 10.8% at 10 mg vs 0.6% placebo)
- Dizziness (up to 3.4%)
- Palpitation (up to 4.5% at 10 mg)
- Flushing (up to 2.6%)
- Fatigue (4.5%)
- Nausea (2.9%)
Serious
- Symptomatic hypotension
- Worsening angina or acute myocardial infarction on starting or increasing the dose (severe obstructive coronary disease)
Most common adverse reaction to amlodipine is edema which occurred in a dose related manner. Other adverse experiences not dose related but reported with an incidence >1.0% are fatigue, nausea, abdominal pain, and somnolence. (6) To report SUSPECTED ADVERSE REACTIONS, contact Viatris at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. NORVASC has been evaluated for safety in more than 11,000 patients in U.S. and foreign clinical trials.
In general, treatment with NORVASC was well‑tolerated at doses up to 10 mg daily. Most adverse reactions reported during therapy with NORVASC were of mild or moderate severity. In controlled clinical trials directly comparing NORVASC (N=1730) at doses up to 10 mg to placebo (N=1250), discontinuation of NORVASC because of adverse reactions was required in only about 1.5% of patients and was not significantly different from placebo (about 1%).
The most commonly reported side effects more frequent than placebo are reflected in the table below. The incidence (%) of side effects that occurred in a dose related manner are as follows: Amlodipine Placebo 2.5 mg 5 mg 10 mg N=275 N=296 N=268 N=520 Edema 1.8 3.0 10.8 0.6 Dizziness 1.1 3.4 3.4 1.5 Flushing 0.7 1.4 2.6 0.0 Palpitation 0.7 1.4 4.5 0.6 Other adverse reactions that were not clearly dose related but were reported with an incidence greater than 1.0% in placebo‑controlled clinical trials include the following: NORVASC (%) Placebo (%) (N=1730) (N=1250) Fatigue 4.5 2.8 Nausea 2.9 1.9 Abdominal Pain 1.6 0.3 Somnolence 1.4 0.6 For several adverse experiences that appear to be drug and dose related, there was a greater incidence in women than men associated with amlodipine treatment as shown in the following table: NORVASC Placebo Male=% Female=% Male=% Female=% (N=1218) (N=512) (N=914) (N=336) Edema 5.6 14.6 1.4 5.1 Flushing 1.5 4.5 0.3 0.9 Palpitations 1.4 3.3 0.9 0.9 Somnolence 1.3 1.6 0.8 0.3 The following events occurred in <1% but >0.1% of patients in controlled clinical trials or under conditions of open trials or marketing experience where a causal relationship is uncertain; they are listed to alert the physician to a possible relationship: Cardiovascular: arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, peripheral ischemia, syncope, tachycardia, vasculitis.
Central and Peripheral Nervous System: hypoesthesia, neuropathy peripheral, paresthesia, tremor, vertigo. Gastrointestinal: anorexia, constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia. General: allergic reaction, asthenia, 1 back pain, hot flushes, malaise, pain, rigors, weight gain, weight decrease.
Musculoskeletal System: arthralgia, arthrosis, muscle cramps, 1 myalgia. Psychiatric: sexual dysfunction (male 1 and female), insomnia, nervousness, depression, abnormal dreams, anxiety, depersonalization. Respiratory System: dyspnea, 1 epistaxis. Skin and Appendages: angioedema, erythema multiforme, pruritus, 1 rash, 1 rash erythematous, rash maculopapular.
Special Senses: abnormal vision, conjunctivitis, diplopia, eye pain, tinnitus. Urinary System: micturition frequency, micturition disorder, nocturia. Autonomic Nervous System: dry mouth, sweating increased. Metabolic and Nutritional: hyperglycemia, thirst. Hemopoietic: leukopenia, purpura, thrombocytopenia. 1 These events occurred in less than 1% in placebo‑controlled trials, but the incidence of these side effects was between 1% and 2% in all multiple dose studies.
NORVASC therapy has not been associated with clinically significant changes in routine laboratory tests. No clinically relevant changes were noted in serum potassium, serum glucose, total triglycerides, total cholesterol, HDL cholesterol, uric acid, blood urea nitrogen, or creatinine. In the CAMELOT and PREVENT studies [see Clinical Studies (14.4)], the adverse event profile was similar to that reported previously (see above), with the most common adverse event being peripheral edema.
6.2 Postmarketing Experience
6.2 Postmarketing Experience Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The following postmarketing event has been reported infrequently where a causal relationship is uncertain: gynecomastia.
In postmarketing experience, jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis), in some cases severe enough to require hospitalization, have been reported in association with use of amlodipine. Postmarketing reporting has also revealed a possible association between extrapyramidal disorder and amlodipine.
NORVASC has been used safely in patients with chronic obstructive pulmonary disease, well‑compensated congestive heart failure, coronary artery disease, peripheral vascular disease, diabetes mellitus, and abnormal lipid profiles.
Adverse reaction frequency tables (US label) US FDA label
| Amlodipine | Placebo | |||
| 2.5 mg | 5 mg | 10 mg | ||
| N=275 | N=296 | N=268 | N=520 | |
| Edema | 1.8 | 3.0 | 10.8 | 0.6 |
| Dizziness | 1.1 | 3.4 | 3.4 | 1.5 |
| Flushing | 0.7 | 1.4 | 2.6 | 0.0 |
| Palpitation | 0.7 | 1.4 | 4.5 | 0.6 |
| NORVASC (%) | Placebo (%) | |
| (N=1730) | (N=1250) | |
| Fatigue | 4.5 | 2.8 |
| Nausea | 2.9 | 1.9 |
| Abdominal Pain | 1.6 | 0.3 |
| Somnolence | 1.4 | 0.6 |
| NORVASC | Placebo | |||
| Male=% | Female=% | Male=% | Female=% | |
| (N=1218) | (N=512) | (N=914) | (N=336) | |
| Edema | 5.6 | 14.6 | 1.4 | 5.1 |
| Flushing | 1.5 | 4.5 | 0.3 | 0.9 |
| Palpitations | 1.4 | 3.3 | 0.9 | 0.9 |
| Somnolence | 1.3 | 1.6 | 0.8 | 0.3 |
Monitoring parameters
- Blood pressure, edema. Lower starting dose (2.5 mg) in older adults and hepatic impairment (label). Kidney
- Blood pressure and heart rate
- Peripheral edema
- Cyclosporine or tacrolimus trough levels after starting or changing the dose
Pregnancy considerations
Pregnancy (US label) US FDA label
8.1 Pregnancy Risk Summary The limited available data based on post-marketing reports with NORVASC use in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. There are risks to the mother and fetus associated with poorly controlled hypertension in pregnancy [see Clinical Considerations].
In animal reproduction studies, there was no evidence of adverse developmental effects when pregnant rats and rabbits were treated orally with amlodipine maleate during organogenesis at doses approximately 10 and 20-times the maximum recommended human dose (MRHD), respectively. However for rats, litter size was significantly decreased (by about 50%) and the number of intrauterine deaths was significantly increased (about 5-fold).
Amlodipine has been shown to prolong both the gestation period and the duration of labor in rats at this dose [see Data]. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%-4% and 15%‑20%, respectively.
Clinical Considerations Disease-associated maternal and/or embryo/fetal risk Hypertension in pregnancy increases the maternal risk for pre-eclampsia, gestational diabetes, premature delivery, and delivery complications (e.g., need for cesarean section and post-partum hemorrhage). Hypertension increases the fetal risk for intrauterine growth restriction and intrauterine death.
Pregnant women with hypertension should be carefully monitored and managed accordingly. Data Animal Data No evidence of teratogenicity or other embryo/fetal toxicity was found when pregnant rats and rabbits were treated orally with amlodipine maleate at doses up to 10 mg amlodipine/kg/day (approximately 10 and 20 times the MRHD based on body surface area, respectively) during their respective periods of major organogenesis.
However for rats, litter size was significantly decreased (by about 50%) and the number of intrauterine deaths was significantly increased (about 5‑fold) in rats receiving amlodipine maleate at a dose equivalent to 10 mg amlodipine/kg/day for 14 days before mating and throughout mating and gestation. Amlodipine maleate has been shown to prolong both the gestation period and the duration of labor in rats at this dose.
Mechanism of action
12.1 Mechanism of Action Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow‑channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites.
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells.
Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses. Serum calcium concentration is not affected by amlodipine. Within the physiologic pH range, amlodipine is an ionized compound (pKa=8.6), and its kinetic interaction with the calcium channel receptor is characterized by a gradual rate of association and dissociation with the receptor binding site, resulting in a gradual onset of effect.
Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. The precise mechanisms by which amlodipine relieves angina have not been fully delineated, but are thought to include the following: Exertional Angina: In patients with exertional angina, NORVASC reduces the total peripheral resistance (afterload) against which the heart works and reduces the rate pressure product, and thus myocardial oxygen demand, at any given level of exercise.
Vasospastic Angina: NORVASC has been demonstrated to block constriction and restore blood flow in coronary arteries and arterioles in response to calcium, potassium epinephrine, serotonin, and thromboxane A2 analog in experimental animal models and in human coronary vessels in vitro. This inhibition of coronary spasm is responsible for the effectiveness of NORVASC in vasospastic (Prinzmetal’s or variant) angina.
US FDA labelPharmacodynamics
Pharmacodynamics (US label) US FDA label
12.2 Pharmacodynamics Hemodynamics: Following administration of therapeutic doses to patients with hypertension, NORVASC produces vasodilation resulting in a reduction of supine and standing blood pressures. These decreases in blood pressure are not accompanied by a significant change in heart rate or plasma catecholamine levels with chronic dosing.
Although the acute intravenous administration of amlodipine decreases arterial blood pressure and increases heart rate in hemodynamic studies of patients with chronic stable angina, chronic oral administration of amlodipine in clinical trials did not lead to clinically significant changes in heart rate or blood pressures in normotensive patients with angina. With chronic once daily oral administration, antihypertensive effectiveness is maintained for at least 24 hours.
Plasma concentrations correlate with effect in both young and elderly patients. The magnitude of reduction in blood pressure with NORVASC is also correlated with the height of pretreatment elevation; thus, individuals with moderate hypertension (diastolic pressure 105–114 mmHg) had about a 50% greater response than patients with mild hypertension (diastolic pressure 90–104 mmHg).
Normotensive subjects experienced no clinically significant change in blood pressures (+1/–2 mmHg). In hypertensive patients with normal renal function, therapeutic doses of NORVASC resulted in a decrease in renal vascular resistance and an increase in glomerular filtration rate and effective renal plasma flow without change in filtration fraction or proteinuria.
As with other calcium channel blockers, hemodynamic measurements of cardiac function at rest and during exercise (or pacing) in patients with normal ventricular function treated with NORVASC have generally demonstrated a small increase in cardiac index without significant influence on dP/dt or on left ventricular end diastolic pressure or volume. In hemodynamic studies, NORVASC has not been associated with a negative inotropic effect when administered in the therapeutic dose range to intact animals and man, even when co‑administered with beta‑blockers to man.
Similar findings, however, have been observed in normal or well‑compensated patients with heart failure with agents possessing significant negative inotropic effects. Electrophysiologic Effects: NORVASC does not change sinoatrial nodal function or atrioventricular conduction in intact animals or man. In patients with chronic stable angina, intravenous administration of 10 mg did not significantly alter A‑H and H‑V conduction and sinus node recovery time after pacing.
Similar results were obtained in patients receiving NORVASC and concomitant beta-blockers. In clinical studies in which NORVASC was administered in combination with beta‑blockers to patients with either hypertension or angina, no adverse effects on electrocardiographic parameters were observed. In clinical trials with angina patients alone, NORVASC therapy did not alter electrocardiographic intervals or produce higher degrees of AV blocks.
Drug interactions Sildenafil When amlodipine and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect [see Drug Interactions (7.1)].
Pharmacokinetics
Key PK parameters
| Bioavailability | 64% to 90% |
|---|---|
| Time to peak | 6 to 12 hours |
| Half-life | About 30 to 50 hours (terminal elimination; label) |
| Half-life in kidney failure (ESKD) kidney | Not separately reported; PK not significantly influenced by renal impairment (label). |
| Protein binding | About 93% |
| Metabolism (CYP, transporters) | Extensive (about 90%) hepatic conversion to inactive metabolites; CYP3A substrate |
| Active metabolites | None (metabolites inactive) |
| Renal excretion kidney | 10% as parent and 60% as metabolites in urine |
| Dialyzability kidney | No: highly protein bound; hemodialysis not likely to help (label). |
Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine.
Elimination from the plasma is biphasic with a terminal elimination half‑life of about 30–50 hours.
Pharmacokinetics (US label) US FDA label
12.3 Pharmacokinetics After oral administration of therapeutic doses of NORVASC, absorption produces peak plasma concentrations between 6 and 12 hours. Absolute bioavailability has been estimated to be between 64 and 90%. The bioavailability of NORVASC is not altered by the presence of food. Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine.
Ex vivo studies have shown that approximately 93% of the circulating drug is bound to plasma proteins in hypertensive patients. Elimination from the plasma is biphasic with a terminal elimination half‑life of about 30–50 hours. Steady‑state plasma levels of amlodipine are reached after 7 to 8 days of consecutive daily dosing.
The pharmacokinetics of amlodipine are not significantly influenced by renal impairment. Patients with renal failure may therefore receive the usual initial dose. Elderly patients and patients with hepatic insufficiency have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40–60%, and a lower initial dose may be required.
A similar increase in AUC was observed in patients with moderate to severe heart failure. Drug interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Impact of other drugs on amlodipine Co-administered cimetidine, magnesium-and aluminum hydroxide antacids, sildenafil, and grapefruit juice have no impact on the exposure to amlodipine.
CYP3A inhibitors: Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure. Erythromycin co-administration in healthy volunteers did not significantly change amlodipine systemic exposure. However, strong inhibitors of CYP3A (e.g., itraconazole, clarithromycin) may increase the plasma concentrations of amlodipine to a greater extent [see Drug Interactions (7.1)].
Impact of amlodipine on other drugs Amlodipine is a weak inhibitor of CYP3A and may increase exposure to CYP3A substrates. Co-administered amlodipine does not affect the exposure to atorvastatin, digoxin, ethanol and the warfarin prothrombin response time. Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone [see Drug Interactions (7.2)].
Cyclosporine: A prospective study in renal transplant patients (N=11) showed on an average of 40% increase in trough cyclosporine levels when concomitantly treated with amlodipine [see Drug Interactions (7.2)]. Tacrolimus: A prospective study in healthy Chinese volunteers (N=9) with CYP3A5 expressers showed a 2.5- to 4-fold increase in tacrolimus exposure when concomitantly administered with amlodipine compared to tacrolimus alone.
This finding was not observed in CYP3A5 non-expressers (N= 6). However, a 3-fold increase in plasma exposure to tacrolimus in a renal transplant patient (CYP3A5 non-expresser) upon initiation of amlodipine for the treatment of post-transplant hypertension resulting in reduction of tacrolimus dose has been reported. Irrespective of the CYP3A5 genotype status, the possibility of an interaction cannot be excluded with these drugs [see Drug Interactions (7.2)].
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Amlodipine 5 mg Tablet | ₱0.20–₱2.68Reference ₱0.39 | per tablet | DPRI procurement range |
| Amlodipine 10 mg Tablet | ₱0.30–₱6.00Reference ₱0.53 | per tablet | DPRI procurement range |
| 5 mg (as besilate/camsylate) tablet | ₱4.50 | per tablet | PhilHealth GAMOT fixed fee |
| 10 mg (as besilate/camsylate) tablet | ₱6.50 | per tablet | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Amlodipine (as besilate/camsylate) |
| PNF listing | Oral: 5 mg and 10 mg tablet |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
| PhilHealth YAKAP (formerly Konsulta) | Yes |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Norvasc · Viatris Specialty LLC [US FDA-approved label, version 10, February 15, 2023]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7367289c-b0b0-466a-83e2-558e2985c29f
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Viatris Specialty LLC. (2023). Norvasc (amlodipine besylate) [Prescribing information; US FDA-approved label, NDA019787, set ID 7367289c-b0b0-466a-83e2-558e2985c29f, version effective February 15, 2023]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7367289c-b0b0-466a-83e2-558e2985c29f
- Schwartz, G. J., Muñoz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20(3), 629–637. https://doi.org/10.1681/ASN.2008030287
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026.
Last updated: .



